vimarsana.com

Page 8 - ஐரோப்பிய தொழிற்சங்கம் உறுப்பினர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Switzerland: BioVersys Receives €20 Million in EU Financing to Support Development of New Antibiotic

    European Investment Bank and BioVersys sign a financing agreement of up to €20 million to facilitate the development of new treatments against life-threatening resistant bacterial infections. The venture debt loan is financed under the Infectious Diseases Finance Facility set up as part.

Switzerland: BioVersys Receives €20 Million in EU Financing to Support Development of New Antibiotics

Switzerland: BioVersys Receives €20 Million in EU Financing to Support Development of New Antibiotics
b3cnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from b3cnewswire.com Daily Mail and Mail on Sunday newspapers.

INTERVIEW WITH Porthos - Bellona org

Komunikat spółki - CEZ Report On Payments To The Government For 2020

Arrivals from Lithuania, Latvia, Finland to undergo entry restrictions entering Estonia | Politics

Lithuania – 312.12 Finland – 164.53 “The restriction on freedom of movement can be shortened by two tests. People who have had COVID-19 disease or a vaccination course in the last six months are exempt from the restriction on freedom of movement and testing,” the Ministry explains. As a result, starting from April 5, Monday, arrivals from the following countries will encounter entry restrictions upon arrival in Estonia: Andorra, Austria, Belgium, Bulgaria, Spain, the Netherlands, Croatia, Ireland, Italy, Greece, Cyprus, Lithuania, Luxembourg, Latvia, Malta, Monaco, Norway, Poland, France, Sweden, Romania, Germany, San Marino, Slovakia, Slovenia, Finland, Switzerland, the Czech Republic and Hungary. All travellers reaching Estonia from these countries will have to isolate for a period of ten days since the infection rate in these countries is more than 150 people per 100,000 inhabitants in the last 14 days.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.